Psychedelics reopening windows of development in mice
Antonia Eisenkoeck
TL;DR
This study shows that psychedelic drugs can reopen a developmental window in mice, with effects linked to how long the drugs' subjective effects last in humans.
Contribution
The study reveals a shared mechanism across psychedelics that correlates subjective effects in humans with developmental changes in mice.
Findings
Psychedelics can reopen a critical developmental period in mice.
The effect duration correlates with the subjective effects' duration in humans.
Abstract
A new study in Nature shows psychedelics’ ability to reopen a critical period of development in mice. This shared property across psychedelic drugs was proportional to the duration of acute subjective effects of the drugs in humans.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPsychedelics and Drug Studies · Chemical synthesis and alkaloids · Neurotransmitter Receptor Influence on Behavior
Pawel Czerwinski on unsplash.com
Psychedelics are a group of drugs associated with altered states of consciousness. They have been used for therapeutic and spiritual purposes by various cultures for thousands of years. Recently, psychedelics have received renewed interest, not least because of their potential application in treatment for mental health conditions such as depression, addiction or PTSD.
But psychedelic drugs vary greatly in their chemical properties, which raises the question: do effects of these drugs on the brain rely on the same mechanism?
Romain Nardou and colleagues at Johns Hopkins University addressed this knowledge gap by studying the effects of psychedelics on social behaviour in mice. Mice form positive associations with socializing—but only during a critical period in adolescence. Nardou and team found that adult mice treated with the psychedelics LSD, psilocybin, MDMA or ketamine found social experiences more rewarding than mice treated with saline or cocaine^1^. This suggests a unifying mechanism of psychedelics reinstating the youthful critical period—an effect which was proportional to the respective drug’s duration of acute subjective effects in humans. Neurons in the brains of mice treated with psychedelics had become more sensitive to the hormone oxytocin, which is further evidence for an induced ‘metaplasticity’ assumed to underlie the establishment of critical periods.
This novel conceptual framework of the underlying mechanisms of psychedelics, opens up avenues for future research and discourse. If research shows that it is applicable to humans, this will have relevance for clinical practice, in which a nuanced understanding of brain plasticity and its ability to positively change cognition and behaviour is key.